Amgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after it was turned down by the regulator because of safety concerns. The agency approved Evenity (romosozumab ...

When deciding which postmenopausal women under 65 to screen, the USPSTF recommended that clinicians first take stock of risk ...

Each year, more than 853,000 people on Medicare use at least one of the 64 medications, according to the Centers for Medicare ...

Some of the drugs on the list included Merck’s Zerbaxa, Johnson & Johnson’s Talvey, Bristol Myers’ Abecma, Astella Pharma Inc.'s Cresemba, and Amgen Inc.'s Evenity. The drugs are typically ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

The success was mainly due to drugs like Tezspire, Blincyto, Evenity, and Tavneos. The company’s sales growth was mainly due ...

Starting in 2025, over 850,000 Americans with Medicare will benefit from lower prescription drug costs as part of the Inflation Reduction Act.

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Today, Benzinga's options scanner spotted 11 options trades for Amgen. This isn't normal. The overall sentiment of these ...

The thyroid medication levothyroxine should be taken on an empty stomach at around the same time every day. You should avoid eating or drinking for 30 minutes to one hour after taking it. There are ...

When a medication works right, it boosts your health or helps you feel better. But a drug can bring on problems if it doesn't mix well with something else you put into your body, like another ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.